• Something wrong with this record ?

The effect of single and repeated doses of rivastigmine on gastric myoelectric activity in experimental pigs

CC. Tsianou, J. Kvetina, V. Radochova, D. Kohoutova, S. Rejchrt, M. Valis, J. Zdarova Karasova, I. Tacheci, V. Knoblochova, O. Soukup, J. Bures

. 2023 ; 18 (6) : e0286386. [pub] 20230601

Language English Country United States

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc23011147

BACKGROUND: Rivastigmine is a pseudo-irreversible cholinesterase inhibitor used for therapy of Alzheimer's disease and non-Alzheimer dementia syndromes. In humans, rivastigmine can cause significant gastrointestinal side effects that can limit its clinical use. The aim of this study was to assess the impact of rivastigmine on gastric motor function by means of electrogastrography (EGG) in experimental pigs. METHODS: Six experimental adult female pigs (Sus scrofa f. domestica, hybrids of Czech White and Landrace breeds; 3-month-old; mean weight 30.7 ± 1.2 kg) were enrolled into the study twice and created two experimental groups. In group A, a single intragastric dose of 6 mg rivastigmine hydrogen tartate was administered in the morning to fasting pigs before EGG recording. In group B, rivastigmine was administered to overnight fasting animals in a dietary bolus in the morning for 7 days (6 mg per day). On day 8, an intragastric dose of 12 mg rivastigmine was given in the morning to fasting pigs before EGG. EGG recording was accomplished by means of an EGG standalone system. Recordings from both groups were evaluated in dominant frequency and EGG power (areas of amplitudes). RESULTS: In total, 1,980 one-minute EGG intervals were evaluated. In group A, basal EGG power (median 1290.5; interquartile range 736.5-2330 μV2) was significantly higher in comparison with the power of intervals T6 (882; 577-1375; p = 0.001) and T10 (992.5; 385-2859; p = 0.032). In group B, the dominant frequency increased significantly from basal values (1.97 ± 1.57 cycles per minute) to intervals T9 (3.26 ± 2.16; p < 0.001) and T10 (2.14 ± 1.16; p = 0.012), respectively. In group B, basal EGG power (median 1030.5; interquartile range 549-5093) was significantly higher in comparison with the power of intervals T7 (692.5; 434-1476; p = 0.002) and T8 (799; 435-1463 μV2; p = 0.004). CONCLUSIONS: Both single as well as repeated intragastric administration of rivastigmine hydrogen tartrate caused a significant decrease of EGG power (areas of amplitudes) in experimental pigs. EGG power may serve as an indirect indicator of gastric motor competence. These findings might provide a possible explanation of rivastigmine-associated dyspepsia in humans.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23011147
003      
CZ-PrNML
005      
20230801132832.0
007      
ta
008      
230718s2023 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1371/journal.pone.0286386 $2 doi
035    __
$a (PubMed)37262057
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Tsianou, Chrysostomi Christina $u Biomedical Research Centre, University Hospital, Hradec Kralove, Czech Republic
245    14
$a The effect of single and repeated doses of rivastigmine on gastric myoelectric activity in experimental pigs / $c CC. Tsianou, J. Kvetina, V. Radochova, D. Kohoutova, S. Rejchrt, M. Valis, J. Zdarova Karasova, I. Tacheci, V. Knoblochova, O. Soukup, J. Bures
520    9_
$a BACKGROUND: Rivastigmine is a pseudo-irreversible cholinesterase inhibitor used for therapy of Alzheimer's disease and non-Alzheimer dementia syndromes. In humans, rivastigmine can cause significant gastrointestinal side effects that can limit its clinical use. The aim of this study was to assess the impact of rivastigmine on gastric motor function by means of electrogastrography (EGG) in experimental pigs. METHODS: Six experimental adult female pigs (Sus scrofa f. domestica, hybrids of Czech White and Landrace breeds; 3-month-old; mean weight 30.7 ± 1.2 kg) were enrolled into the study twice and created two experimental groups. In group A, a single intragastric dose of 6 mg rivastigmine hydrogen tartate was administered in the morning to fasting pigs before EGG recording. In group B, rivastigmine was administered to overnight fasting animals in a dietary bolus in the morning for 7 days (6 mg per day). On day 8, an intragastric dose of 12 mg rivastigmine was given in the morning to fasting pigs before EGG. EGG recording was accomplished by means of an EGG standalone system. Recordings from both groups were evaluated in dominant frequency and EGG power (areas of amplitudes). RESULTS: In total, 1,980 one-minute EGG intervals were evaluated. In group A, basal EGG power (median 1290.5; interquartile range 736.5-2330 μV2) was significantly higher in comparison with the power of intervals T6 (882; 577-1375; p = 0.001) and T10 (992.5; 385-2859; p = 0.032). In group B, the dominant frequency increased significantly from basal values (1.97 ± 1.57 cycles per minute) to intervals T9 (3.26 ± 2.16; p < 0.001) and T10 (2.14 ± 1.16; p = 0.012), respectively. In group B, basal EGG power (median 1030.5; interquartile range 549-5093) was significantly higher in comparison with the power of intervals T7 (692.5; 434-1476; p = 0.002) and T8 (799; 435-1463 μV2; p = 0.004). CONCLUSIONS: Both single as well as repeated intragastric administration of rivastigmine hydrogen tartrate caused a significant decrease of EGG power (areas of amplitudes) in experimental pigs. EGG power may serve as an indirect indicator of gastric motor competence. These findings might provide a possible explanation of rivastigmine-associated dyspepsia in humans.
650    _2
$a lidé $7 D006801
650    _2
$a zvířata $7 D000818
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a kojenec $7 D007223
650    _2
$a rivastigmin $x farmakologie $7 D000068836
650    12
$a žaludek $7 D013270
650    12
$a Alzheimerova nemoc $7 D000544
650    _2
$a gastrointestinální trakt $7 D041981
650    _2
$a elektromyografie $7 D004576
650    _2
$a cholinesterasové inhibitory $x farmakologie $7 D002800
650    _2
$a fenylkarbamáty $x farmakologie $7 D048448
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Kvetina, Jaroslav $u Biomedical Research Centre, University Hospital, Hradec Kralove, Czech Republic
700    1_
$a Radochova, Vera $u Animal Laboratory, Faculty of Military Health Sciences, University of Defence, Hradec Kralove, Czech Republic $1 https://orcid.org/0000000214775451
700    1_
$a Kohoutova, Darina $u Biomedical Research Centre, University Hospital, Hradec Kralove, Czech Republic $u The Royal Marsden NHS Foundation Trust, London, United Kingdom
700    1_
$a Rejchrt, Stanislav $u 2nd Department of Internal Medicine-Gastroenterology, Faculty of Medicine in Hradec Kralove and University Hospital Hradec Kralove, Charles University, Hradec Kralove, Czech Republic $1 https://orcid.org/0000000151669503 $7 mzk2005306779
700    1_
$a Valis, Martin $u Department of Neurology, Faculty of Medicine in Hradec Kralove and University Hospital Hradec Kralove, Charles University, Hradec Kralove, Czech Republic
700    1_
$a Zdarova Karasova, Jana $u Biomedical Research Centre, University Hospital, Hradec Kralove, Czech Republic $u Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence, Hradec Kralove, Czech Republic $1 https://orcid.org/0000000308919591 $7 xx0099787
700    1_
$a Tacheci, Ilja $u 2nd Department of Internal Medicine-Gastroenterology, Faculty of Medicine in Hradec Kralove and University Hospital Hradec Kralove, Charles University, Hradec Kralove, Czech Republic
700    1_
$a Knoblochova, Veronika $u Biomedical Research Centre, University Hospital, Hradec Kralove, Czech Republic
700    1_
$a Soukup, Ondrej $u Biomedical Research Centre, University Hospital, Hradec Kralove, Czech Republic
700    1_
$a Bures, Jan $u Biomedical Research Centre, University Hospital, Hradec Kralove, Czech Republic $u Institute of Gastrointestinal Oncology, Military University Hospital Praha, Praha, Czech Republic $u Department of Medicine, First Faculty of Medicine, Charles University, Nové Město, Czech Republic $u Military University Hospital Praha, Praha, Czech Republic $1 https://orcid.org/000000030326117X $7 nlk19990073060
773    0_
$w MED00180950 $t PloS one $x 1932-6203 $g Roč. 18, č. 6 (2023), s. e0286386
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37262057 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230718 $b ABA008
991    __
$a 20230801132829 $b ABA008
999    __
$a ok $b bmc $g 1963504 $s 1197412
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 18 $c 6 $d e0286386 $e 20230601 $i 1932-6203 $m PLoS One $n PLoS One $x MED00180950
LZP    __
$a Pubmed-20230718

Find record

Citation metrics

Archiving options